roco semaglutide Ro Is Prescribing Compounded Semaglutide, Despite Doctors' Warnings Ro's Weight-Loss Program Review: GLP-1

Novo Nordisk reported 2025 sales of 309-billion Danish krone, about $67-billion, more than half of which came from selling Ozempic and Wegovy in the United States [Source: theglobeandmail.com/business/economy/article-apotex-fda-approval-generic-ozempic-drug-health-canada-decisions/]

Non-GLP-1 agents are most appropriate for patients unable to tolerate GLP-1 medications, those with GLP-1 contraindications (such as personal or family history of medullary thyroid carcinoma), or individuals requiring different metabolic pathways

For instance, those with chronic pain reported less pain and better mobility

Note: the blue colouration of reconstituted GHK-Cu is normal and due to the copper complex

That is your volume